Ann: Further wide high-grade gold intercepts at El Zorro, page-73

First 73 Last

Share
Profile

Follow
Tubsfahkwah

4,802 Posts.

303

07/05/20

16:21

Post #: 44493262
Share

Originally posted by sneakerlover: ↑

This is a summary of what I've learned by reading from posters here.

1. Hold - if you are in for the long term. We're talking 1 year and up. There could be a good chance things get going by the year's end. I think Corgi is the one who mentioned we might see results by then. But again, don't take anyone's word for what it is. DYOR and risk assessment.

2. If you're not looking to for long term or are not able to hold out that long, sell at a price you think is good. And don't look back even if the price continues to go up. No one knows how high it can go and how low it can go. There was a trader here who sold at 6c+ but it continued upwards to 9c. The point is he made his money and should be satisfied with it. No point beating yourself up for it.

3. If you bought at high and is suffering a loss now, well you should look into stop-loss. I am guilty of this as well for other stock. But if you don't need the money or have more to spare, you could average down like Ausbuddy. But definitely look into stop-loss as a priority.

4. Everyone is looking to get out at some point and when they do they usually don't tell you. So blindly following someone's words here is not advisable. Things change and so must our view/opinion on a stock.

5. Good luck to all. This is just the humble 2 cents of the teacher in me.

Expand

50% retracement off the 9c high is 4.5c right? Most traders will pick it up I suspect.

TSO Price at posting: 4.7¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 20 more messages in this thread...

First 73 Last

Add TSO (ASX) to my watchlist

(20min delay)
Last 3.5¢		Change 0.001(2.94%)		Mkt cap ! $54.36M

Open	High	Low	Value	Volume
3.5¢	3.5¢	3.5¢	$0	1

Buyers (Bids)

No.	Vol.	Price($)
1	28116	3.5¢

Sellers (Offers)

Price($)	Vol.	No.
3.6¢	150000	2

View Market Depth

No.	Vol.	Price($)
1	28116	0.035
1	300000	0.034
2	115626	0.032
5	2715131	0.030
1	500000	0.029

Price($)	Vol.	No.
0.036	150000	2
0.037	380079	2
0.038	1068207	4
0.039	1072080	3
0.040	942768	3

Last trade - 13.15pm 07/10/2024 (20 minute delay)

TSO (ASX) Chart

Ann: Further wide high-grade gold intercepts at El Zorro, page-73

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Further wide high-grade gold intercepts at El Zorro, page-73

Top Stories

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News